GO:0010715 regulation of extracellular matrix disassembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010715 (regulation of extracellular matrix disassembly) is a biological process that modulates the rate, frequency, or extent of extracellular matrix breakdown.
• Extracellular matrix disassembly is essential for tissue remodeling, cell migration, and biofilm dispersion, and its dysregulation contributes to cancer, fibrosis, and inflammatory diseases.
• Key regulators include matrix metalloproteinases (MMPs), their inhibitors (TIMPs), and epigenetic modifiers such as BAF chromatin remodeller and Mir221/222.
• The process is controlled by quorum sensing in bacteria and by transcriptional and epigenetic programs in eukaryotes.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal interrogation of regulatory genes in ECM disassembly.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate ECM disassembly research.
Description
The extracellular matrix (ECM) is a dynamic network of proteins and polysaccharides that provides structural support and biochemical cues to cells. Regulation of extracellular matrix disassembly (GO:0010715) encompasses any process that modulates the rate, frequency, or extent of ECM breakdown. This regulatory process is critical for normal development, tissue repair, and immune responses, but its dysregulation underlies numerous pathologies, including cancer invasion, fibrosis, and chronic inflammatory diseases. Understanding how ECM disassembly is controlled at the molecular level is therefore a major research focus. Recent studies have identified diverse regulators, from bacterial quorum-sensing systems to eukaryotic chromatin remodellers and microRNAs, that impinge on ECM turnover. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of GO:0010715, its mechanisms, key genes, disease relevance, and experimental strategies for investigation.
regulation of extracellular matrix disassembly At A Glance
| GO ID | GO:0010715 |
|---|---|
| GO term | regulation of extracellular matrix disassembly |
| Ontology | biological_process |
| Synonym | regulation of extracellular matrix breakdown; regulation of extracellular matrix degradation |
| Major function | Modulates the rate, frequency, or extent of extracellular matrix breakdown |
| Related processes | ECM disassembly, tissue remodeling, cell migration, biofilm dispersion |
| Key regulators | MMPs, TIMPs, quorum-sensing factors, chromatin remodellers, microRNAs |
| Disease relevance | Cancer, fibrosis, inflammatory bowel disease, arthritis |
What Is GO:0010715?
According to the Gene Ontology, GO:0010715 (regulation of extracellular matrix disassembly) is defined as any process that modulates the rate, frequency, or extent of extracellular matrix disassembly, which itself is the breakdown of the extracellular matrix. This term is a biological process and includes synonyms such as regulation of extracellular matrix breakdown and regulation of extracellular matrix degradation. It encompasses both positive and negative regulation, integrating signals from proteases, inhibitors, and cellular signaling pathways.
Why Is regulation of extracellular matrix disassembly Important in Cell Biology?
Regulation of extracellular matrix disassembly is fundamental to tissue homeostasis and repair, and its perturbation is a hallmark of many diseases. In cancer, aberrant ECM breakdown facilitates invasion and metastasis, while in fibrosis, excessive ECM deposition and impaired disassembly lead to organ dysfunction. Inflammatory conditions such as arthritis and inflammatory bowel disease involve dysregulated ECM turnover. Moreover, bacterial biofilm dispersion, a process critical for infection persistence, is controlled by ECM disassembly regulators. Thus, understanding GO:0010715 offers insights into both normal physiology and disease pathogenesis, and it provides targets for therapeutic intervention.
• Controls tissue remodeling during development and wound healing.
• Facilitates cancer cell invasion and metastasis when dysregulated.
• Contributes to fibrosis through imbalanced ECM synthesis and degradation.
• Regulates bacterial biofilm dispersion, impacting chronic infections.
• Influences inflammatory responses in diseases like arthritis and IBD.
• Serves as a target for epigenetic therapies modulating ECM turnover.
• Involved in heart regeneration via agrin-mediated ECM remodeling.
• Provides biomarkers for disease progression and treatment response.
• Enables high-throughput CRISPR screening to identify novel regulators.
• Offers opportunities for bioinformatics-driven discovery of regulatory networks.
What Happens During regulation of extracellular matrix disassembly?
Initiation by Proteolytic Enzymes
In simple terms: Enzymes cut the ECM mesh, starting its breakdown.
ECM disassembly is initiated by proteases such as matrix metalloproteinases (MMPs) that cleave structural components like collagen and elastin. These enzymes are secreted or membrane-bound and are tightly regulated at multiple levels. In bacteria, quorum-sensing signals trigger the production of ECM-degrading enzymes to disperse biofilms.
Regulation by Inhibitors and Signaling
In simple terms: Inhibitors and signals act like brakes and accelerators on ECM breakdown.
Tissue inhibitors of metalloproteinases (TIMPs) bind and inhibit MMPs, providing a balance between ECM synthesis and degradation. Signaling pathways, including those activated by growth factors and cytokines, modulate the expression and activity of these proteases and inhibitors. For example, epigenetic regulators such as the BAF chromatin remodeller can alter the expression of ECM-related genes, thereby influencing disassembly.
Epigenetic and Transcriptional Control
In simple terms: Chemical tags on DNA and histones can turn ECM-degrading genes on or off.
Epigenetic mechanisms, including DNA methylation and histone modifications, regulate the transcription of MMPs and other ECM-remodeling factors. MicroRNAs such as Mir221/222 target chromatin remodeling components and cell cycle inhibitors, indirectly affecting ECM disassembly in synovial hyperplasia. These layers of regulation ensure context-dependent ECM turnover.
Integration with Cellular Processes
In simple terms: ECM breakdown is linked to cell movement, division, and tissue repair.
ECM disassembly is coupled with cell migration, proliferation, and differentiation. For instance, the ECM protein agrin promotes heart regeneration by modulating ECM remodeling and cardiomyocyte proliferation. In intestinal epithelial tight junction barrier regulation, ECM disassembly influences barrier function and inflammation.
Key Genes Involved in GO:0010715 regulation of extracellular matrix disassembly
The following genes and proteins are key players in the regulation of extracellular matrix disassembly, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MMP1 | Collagenase that initiates ECM breakdown | Target in cancer invasion and arthritis |
| MMP2 | Degrades type IV collagen in basement membranes | Associated with metastasis and fibrosis |
| MMP9 | Degrades gelatin and collagen | Involved in inflammation and tissue remodeling |
| TIMP1 | Inhibits MMP activity | Regulates ECM turnover balance |
| TIMP2 | Inhibits MMPs, especially MMP2 | Modulates ECM disassembly in cancer |
| BAF (SMARCA4) | Chromatin remodeller regulating ECM gene expression | Impacts neuroblastoma metastasis |
| Mir221/222 | MicroRNAs targeting chromatin remodelers | Drive synovial hyperplasia and arthritis |
| Agrin | ECM protein promoting heart regeneration | Therapeutic target for cardiac repair |
| Quorum-sensing factors | Bacterial regulators of biofilm dispersion | Target for anti-biofilm strategies |
| EMP/EMT regulators | Epigenetic control of epithelial-mesenchymal transition | Linked to fibrosis and cancer |
| Tight junction proteins | Regulate intestinal barrier and ECM interactions | Inflammatory bowel disease |
| Staphylococcal biofilm components | ECM-like matrix in biofilms | Model for ECM disassembly regulation |
| Chromatin remodeling components | Modulate ECM gene transcription | Cancer and arthritis |
| Cell cycle inhibitors | Indirectly affect ECM disassembly via proliferation | Synovial hyperplasia |
| Epigenetic modifiers | DNA/histone modifications affecting ECM genes | Fibrosis and cancer |
How Is regulation of extracellular matrix disassembly Regulated?
Regulation of extracellular matrix disassembly is governed by a complex interplay of proteases, inhibitors, and signaling pathways. Quorum sensing in bacteria controls the expression of ECM-degrading enzymes in response to population density. In eukaryotes, transcriptional and epigenetic mechanisms, including chromatin remodeling by the BAF complex and microRNA-mediated silencing, fine-tune the expression of MMPs and TIMPs. Additionally, growth factors and cytokines modulate these pathways, ensuring ECM turnover is coordinated with tissue needs.
regulation of extracellular matrix disassembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SMARCA4 (BAF) | Neuroblastoma metastasis | Knockout in neuroblastoma cell lines |
| Mir221/222 | Rheumatoid arthritis | Overexpression in synovial fibroblasts |
| MMP9 | Inflammatory bowel disease | Knockout in intestinal epithelial cells |
| Agrin | Heart regeneration | Knock-in in mouse models |
| TIMP1 | Fibrosis | Overexpression in hepatic stellate cells |
Cancer Invasion and Metastasis
Dysregulated ECM disassembly enables cancer cells to breach basement membranes and invade surrounding tissues. The BAF chromatin remodeller complex regulates an invasiveness epigenomic program, and its disruption impairs neuroblastoma metastasis by altering ECM-related gene expression. MMPs and their inhibitors are frequently imbalanced in tumors, making them attractive therapeutic targets.
Fibrosis and Chronic Inflammation
Excessive ECM deposition and impaired disassembly contribute to fibrosis in organs such as lung, liver, and kidney. Epigenetic regulation of EMP/EMT-dependent fibrosis highlights the role of chromatin modifications in controlling ECM turnover. In inflammatory bowel disease, tight junction barrier regulation intersects with ECM disassembly, influencing disease severity.
Arthritis and Synovial Hyperplasia
In rheumatoid arthritis, synovial hyperplasia is driven by microRNAs such as Mir221/222 that target cell cycle inhibitors and chromatin remodeling components, leading to altered ECM disassembly and joint destruction. Targeting these regulatory pathways may provide new therapeutic avenues.
Bacterial Biofilm Infections
Biofilms are communities of bacteria embedded in an ECM-like matrix. Regulation of ECM disassembly is critical for biofilm dispersion, which contributes to chronic infections. Staphylococcal biofilm development and quorum-sensing control of dispersion are well-studied examples.
From regulation of extracellular matrix disassembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate ECM disassembly? | CRISPR knockout in cell lines |
| What is the effect of a point mutation in MMP active site? | CRISPR point mutation knock-in |
| How does a regulatory element control MMP expression? | Knock-in of reporter or tagged allele |
| Can overexpression of TIMP1 inhibit ECM breakdown? | CRISPR overexpression (CRISPRa) |
| Which genes are essential for biofilm dispersion? | CRISPR library screening in bacteria |
| What is the epigenetic landscape of ECM genes? | Bioinformatics analysis of ChIP-seq/ATAC-seq |
How to Study the regulation of extracellular matrix disassembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for ECM disassembly | Identify novel regulators |
| RNA-seq | Transcriptional changes | Profile ECM gene expression |
| ATAC-seq | Chromatin accessibility | Map regulatory elements |
| Zymography | MMP enzymatic activity | Quantify ECM degradation |
| Proteomics | ECM protein composition | Assess disassembly products |
| Live-cell imaging | Real-time ECM degradation | Visualize invasion |
| Biofilm dispersion assay | Bacterial ECM breakdown | Study quorum sensing |
| Bioinformatics pathway analysis | Enrichment of ECM-related pathways | Interpret omics data |
CRISPR Screening for Regulators
Genome-wide CRISPR knockout or activation screens can identify novel regulators of ECM disassembly. For example, screens in cancer cells have uncovered chromatin remodeling components that control invasiveness. In bacteria, CRISPR interference can be used to study biofilm dispersion genes.
Transcriptomic and Epigenomic Profiling
RNA-seq and ATAC-seq reveal changes in gene expression and chromatin accessibility upon perturbation of candidate regulators. Such approaches have been used to define the epigenomic program of neuroblastoma metastasis and to study epigenetic regulation of fibrosis.
Proteomics and Zymography
Proteomic analysis of ECM components and zymography for MMP activity provide direct measures of ECM disassembly. These methods are essential for validating findings from genetic screens.
Imaging and Functional Assays
Live-cell imaging of ECM degradation, wound healing assays, and biofilm dispersion assays allow real-time monitoring of ECM disassembly regulation. These techniques are widely used in cancer and microbiology research.
How CRISPR Can Be Used to Study GO:0010715 regulation of extracellular matrix disassembly
Knockout
CRISPR knockout of candidate genes (e.g., MMPs, TIMPs, chromatin remodelers) in cell lines or organoids allows assessment of their role in ECM disassembly. For instance, knockout of BAF components impaired neuroblastoma metastasis by reverting an invasiveness epigenomic program.
Point Mutation
Introducing point mutations in catalytic domains of proteases or in regulatory elements can dissect their specific contributions. This approach is useful for studying MMP active-site mutants or TIMP binding interfaces.
Knock-in
Knock-in of reporter genes (e.g., fluorescent tags) or tagged alleles enables real-time tracking of ECM disassembly regulators. Knock-in of agrin variants has been used to study heart regeneration in mice.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate levels of regulators like TIMP1 to test their impact on ECM breakdown. Overexpression of Mir221/222 in synovial fibroblasts recapitulated arthritis phenotypes.
How EDITGENE Supports regulation of extracellular matrix disassembly Research
Researchers studying regulation of extracellular matrix disassembly-related genes often need to determine whether a candidate gene is causally involved in ECM turnover or merely correlated with it. This requires precise genetic manipulation and functional validation. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such investigations, from knockout and point mutation to knock-in and overexpression, along with library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for regulation of extracellular matrix disassembly research.
Frequently Asked Questions About regulation of extracellular matrix disassembly
What is GO:0010715?
GO:0010715 is the Gene Ontology term for regulation of extracellular matrix disassembly, defined as any process that modulates the rate, frequency, or extent of extracellular matrix breakdown.
What genes are involved in regulation of extracellular matrix disassembly?
Key genes include MMPs, TIMPs, BAF chromatin remodeller components, Mir221/222, and agrin, among others.
How is extracellular matrix disassembly regulated?
It is regulated by proteases, inhibitors, quorum-sensing signals, epigenetic modifiers, and microRNAs that control ECM gene expression and activity.
What diseases are associated with dysregulated ECM disassembly?
Cancer, fibrosis, inflammatory bowel disease, arthritis, and chronic biofilm infections are linked to dysregulated ECM disassembly.
What experimental models are used to study ECM disassembly?
CRISPR knockout, point mutation, knock-in, overexpression, and library screening in cell lines, organoids, and animal models are commonly used.
How can CRISPR screening identify regulators of ECM disassembly?
Genome-wide CRISPR screens can pinpoint genes whose loss or activation alters ECM breakdown, revealing novel regulatory pathways.
What is the role of quorum sensing in ECM disassembly?
Quorum sensing controls the expression of ECM-degrading enzymes in bacteria, regulating biofilm dispersion.
Which epigenetic factors regulate ECM disassembly?
Chromatin remodellers like BAF and microRNAs such as Mir221/222 modulate ECM gene transcription and are implicated in cancer and arthritis.
Can ECM disassembly be targeted therapeutically?
Yes, MMP inhibitors, TIMP mimetics, and epigenetic drugs are being explored for cancer, fibrosis, and inflammatory diseases.
What services does EDITGENE offer for ECM disassembly research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to ECM research.
Conclusion
Regulation of extracellular matrix disassembly (GO:0010715) is a pivotal biological process that controls tissue remodeling, cell migration, and microbial biofilm dispersion. Its dysregulation contributes to major human diseases, including cancer, fibrosis, and inflammatory conditions. Advances in CRISPR-based models and high-throughput screening are rapidly expanding our understanding of the regulatory networks involved. EDITGENE's comprehensive services empower researchers to dissect these mechanisms with precision and speed.
References
- 1. Schilcher K et al.. 2020. Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies.. Microbiol Mol Biol Rev 84(3) PMID: 32792334
- 2. Solano C et al.. 2014. Biofilm dispersion and quorum sensing.. Curr Opin Microbiol 18:96-104 PMID: 24657330
- 3. Bassat E et al.. 2017. The extracellular matrix protein agrin promotes heart regeneration in mice.. Nature 547(7662):179-184 PMID: 28581497
- 4. Arumugam P et al.. 2025. Intestinal Epithelial Tight Junction Barrier Regulation by Novel Pathways.. Inflamm Bowel Dis 31(1):259-271 PMID: 39321109
- 5. Jiménez C et al.. 2022. Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program.. Mol Cancer 21(1):175 PMID: 36057593
- 6. Sisto M et al.. 2024. Epigenetic Regulation of EMP/EMT-Dependent Fibrosis.. Int J Mol Sci 25(5) PMID: 38474021
- 8. Roumelioti F et al.. 2024. Mir221/222 drive synovial hyperplasia and arthritis by targeting cell cycle inhibitors and chromatin remodeling components.. Elife 13 PMID: 39235454
